Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study

Review of the New Delayed-Release Oral Tablet and Intravenous Dosage Forms of Posaconazole

(2015) Anthony J. Guarascio et al.   PHARMACOTHERAPY

Risk Factors for Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience

(2013) Aazim K. Omer et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation

(2012) Y. Sun et al.   CLINICAL MICROBIOLOGY AND INFECTION

Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study

(2012) J. Auberger et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Detection of Galactomannan in Bronchoalveolar Lavage Fluid Samples of Patients at Risk for Invasive Pulmonary Aspergillosis: Analytical and Clinical Validity

(2012) J. D'Haese et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The EBMT risk score

(2011) A Gratwohl   BONE MARROW TRANSPLANTATION

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation

(2011) David I. Marks et al.   BRITISH JOURNAL OF HAEMATOLOGY

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

(2010) J Maertens et al.   BONE MARROW TRANSPLANTATION

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

(2010) Dimitrios P. Kontoyiannis et al.   CLINICAL INFECTIOUS DISEASES

Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients

(2010) L. Pagano et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Background to hematopoietic cell transplantation, including post transplant immune recovery

(2009) C Mackall et al.   BONE MARROW TRANSPLANTATION

Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients

(2009) M Mikulska et al.   BONE MARROW TRANSPLANTATION

Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology

(2009) Georg Maschmeyer et al.   EUROPEAN JOURNAL OF CANCER

Epidemiology of Invasive Mold Infections in Allogeneic Stem Cell Transplant Recipients: Biological Risk Factors for Infection According to Time after Transplantation

(2008) Carol Garcia‐Vidal et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry

(2008) D. Neofytos et al.   CLINICAL INFECTIOUS DISEASES

Toll-like Receptor 4 Polymorphisms and Aspergillosis in Stem-Cell Transplantation

(2008) Pierre-Yves Bochud et al.   NEW ENGLAND JOURNAL OF MEDICINE